Brexpiprazole—Pharmacologic Properties and Use in Schizophrenia and Mood Disorders
Sign Up to like & getrecommendations! Published in 2023 at "Brain Sciences"
DOI: 10.3390/brainsci13030397
Abstract: In 2002, the first III generation antipsychotic drug was registered—aripiprazole. Its partial dopaminergic agonism underlies its unique mechanism of action and the potentially beneficial influence on the positive, negative, or cognitive symptoms. Due to its… read more here.
Keywords: properties use; brexpiprazole pharmacologic; drug; mood disorders ... See more keywords